000 | 01752 a2200541 4500 | ||
---|---|---|---|
005 | 20250513123129.0 | ||
264 | 0 | _c19970825 | |
008 | 199708s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRossi, G | |
245 | 0 | 0 |
_aOutbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. _h[electronic resource] |
260 |
_bBlood _cAug 1997 |
||
300 |
_a1309-14 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAgammaglobulinemia _xcomplications |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 | _aDisease Outbreaks |
650 | 0 | 4 | _aDrug Contamination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHematologic Diseases _xcomplications |
650 | 0 | 4 |
_aHepacivirus _xgenetics |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 |
_aHepatitis C Antibodies _xbiosynthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunocompetence |
650 | 0 | 4 | _aImmunocompromised Host |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadverse effects |
650 | 0 | 4 |
_aItaly _xepidemiology |
650 | 0 | 4 |
_aLiver Failure _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aPurpura, Thrombocytopenic, Idiopathic _xcomplications |
650 | 0 | 4 | _aSequence Alignment |
650 | 0 | 4 | _aSequence Homology, Amino Acid |
650 | 0 | 4 | _aSurvival Analysis |
700 | 1 | _aTucci, A | |
700 | 1 | _aCariani, E | |
700 | 1 | _aRavaggi, A | |
700 | 1 | _aRossini, A | |
700 | 1 | _aRadaeli, E | |
773 | 0 |
_tBlood _gvol. 90 _gno. 3 _gp. 1309-14 |
|
999 |
_c9222531 _d9222531 |